Adverse effects of cannabis: Inform psychologically vulnerable patients of the risk of serious, dose-dependent disorders

Prescrire International

Volumn 20, Issue 112, 2011, Pages 18-23

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS;

ALCOHOL CONSUMPTION; ANXIETY; APATHY; CANNABIS ADDICTION; CARDIOVASCULAR RISK; DEPRESSION; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; HIGH RISK PATIENT; HUMAN; INCIDENCE; IRRITABILITY; LONG TERM EXPOSURE; NERVOUSNESS; PSYCHOSIS; REACTION TIME; RESTLESSNESS; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SLEEP DISORDER; SMOKING; SUICIDAL IDEATION;

ADOLESCENT; CANNABIS; FRANCE; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; TETRAHYDROCANNABINOL; TIME FACTORS; YOUNG ADULT;

EID: 78651241546     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Prescrire Rédaction "Consommation de cannabis partout en France" Rev Prescrire 2008; 28 (299): 702-703.
2. "Cannabis". In: ́tat du phénomène de la drogue en Europe. Rapport annuel 2009" Observatoire européen des drogues et des toxicomanies, Luxembourg 2009: 41-52.
3. Observatoire français des drogues et des toxicomanies "Opinions et consommations des français". In: "Drogues et dépendances, données essentielles" éd. La Découverte, Paris 2005: 19-29.
4. Bello PY et al. "Les usagers fréquents de cannabis, éléments descriptifs, France, 2004" BEH2005; (20):89-91.
5. Reynaud-Maurupt C "Les habitués du cannabis. Une enquête qualitative auprès des usagers réguliers" Observatoire français des drogues et des toxicomanies 2009: 311 pages.
6. Kalant H "Adverse effects of cannabis on health: an update of the literature since 1996" Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 849-863.
7. "Cannabis". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 19 March 2010: 7 pages.
8. "Risques, conséquences et effets liés aux usages de cannabis". In: Costes JM "Cannabis, données essentielles" Observatoire français des drogues et des toxicomanies 2007: 88-109.
9. Diplock J et al. "A Review of the research on the risks and harms associated to the use of marijuana" J Global Drug Policy Pract 2009; 3 (2): 8 pages.
10. Price C et al. "Cannabis and suicide: longitudinal study" Br J Psychiatry 2009; 195: 492-497.
11. Grant I et al. "Non-acute residual neurocognitive effects of cannabis use: a meta-analytic study" J Int Neuropsychol Soc 2003; 9: 679-689.
12. Ware MA and Tawfik VL "Safety issues concerning the medical use of cannabis and cannabinoids" Pain Res Manage 2005; 10 (suppl. A): 31-37.
13. Prescrire Editorial Staff "Cannabis and pain" Prescrire Int 2009; 18 (103): 226.
14. Di Forti M et al. "High-potency cannabis and the risk of psychosis" Br J Psychiatry 2009; 195 (6): 488-491.
15. Hall W and Degenhart L "Adverse health effects of non-medical cannabis use" Lancet 2009; 374:1383-1391.
16. Lynskey M and Hall W. "The effecs of adolescent cannabis use on educational attainment: a review" Addiction 2000; 95(11): 1621-1630.
17. Moore THM et al. "Cannabis use and risk of psychotic or affective menthal health outcomes: a systematic review" Lancet 2007; 370: 319-328 +
18. "Webtable 1: Summary of studies included for psychotic outcomes"; www.lancet.com: 4 pages.
19. Andreasson S et al. "Cannabis and schizophrenia. A longitudinal study of Swedish conscripts" Lancet 1987; 2: 1483-1485.
20. Tien AY et al. "Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences" J Nerv Ment Dis 1990; 178 (8) : 473-480.
21. Arseneault L et al "Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study" BMJ 2002; 325: 1212-1213.
22. Van Os J et al "Cannabis use and psychosis: a longitudinal population-based study" Am J Epidemiol 2002; 156: 319-327.
23. Zammit S et al. "Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study" BMJ 2002; 325:1199-1201
24. (full version on www.bmj.com: 5 pages) + "Rapid responses" accessed 16 December 2009: 5 pages.
25. Henquet C et al. "Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people" BMJ 2005; 330:11-14.
26. Wiles NJ et al. "Self-reported psychotic symptoms in the general population" Br J Psychiatry 2006; 188: 519-526.
27. Fergusson DM et al. "Cannabis dependence and psychotic symptoms in young people" Psychol Med 2003; 33 (1): 15-21.
28. van Rossum I et al. "Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis" J Nerv Ment Dis 2009; 197 (1): 35-40.
29. Ferdinand RF et al. "Cannabis use predicts future psychotic symptoms, and vice versa" Addiction 2005; 100 (5): 612-618.
30. Degenhardt L et al. "Testing hypotheses about the relationship between cannabis use and psychosis" Drug Alcohol Depend 2003; 71: 37-48.
31. Negrete JC et al. "Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey" Psychological Medicine 1986; 16: 515-520.
32. Linszen DH et al. "Cannabis abuse and the course of recent-onset schizophrenic disorders" Arch Gen Psychiatry 1994; 51: 273-279.
33. "Données épidémiologiques sur l'abus et la dépendance au cannabis", "Facteurs de vulné rabilité à la consommation abusive de cannabis". In: "Cannabis. Quels effets sur le comportement et la santé ?" Inserm, 2001 Paris: 63-77, 79-92.
34. Hollister LE "Cannabis and the development of tolerance" Adv Biosci 1978; 22-23: 585-589.
35. Roura C and Chabrol H "Symptômes de tolérance, de sevrage et de dépendance au cannabis chez l'adolescent consommateur" Neuropsychiatr Enfance Adolesc 2004; 52: 11-16.
36. Roques B "La dangerosité des drogues" Odile Jacob/La Documentation française, Paris 1999: 317 pages.
37. Budney AJ et al. "Review of the validity and significance of cannabis withdrawal syndrome" Am J Psychiatry 2004; 161 (11): 1967-1977.
38. Copersino ML et al. "Cannabis withdrawal among non-treatment-seeking adult cannabis users" Am J Addict 2006; 15: 8-14.
39. Prescrire Rédaction "Cannabis, alcool et conduite automobile: priorité aux données" Rev Prescrire 2006; 26 (272): 380-381.
40. Aronow WS and Cassidy J "Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris" Clin Pharmacol Ther 1975 ; 17 (5) : 549-554.
41. Rbaibi A et al. "Complications cardiovasculaires des intoxications au cannabis" Rev Med Intern 2008 ; 29 (suppl.) (abstr. CA163): 398.
42. Mittelman MA et al. "Triggering myocardial infarction by marijuana" Circulation 2001; 103: 2805-2809.
43. Peyrot et al. "Cannabis arteritis: a new case report and a review of literature" J Eur Acad Dermatol Venereol 2007; 21: 388-391.
44. Vignot S et al. "Cannabis et cancer" Bull Cancer 2006; 93 (2): 163-170.
45. Hashibe M et al. "Epidemiologic review of marijuana use and cancer risk" Alcohol 2005; 35: 265-275.
46. Tetrault JM et al. "Effects of marijuana smoking on pulmonary function and respiratory complications" Arch Intern Med 2007; 167: 221-228.
47. Daling JR et al. "Association of marijuana use and the incidence of testicular germ cell tumors" Cancer 2009; 115 (6): 1215-1223.
48. Hézode C et al. "Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C" Hepatology 2005; 42(1): 63-71.
49. Hézode C et al. "Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C" Gastroenterology 2008; 134: 432-439.
50. Ishida JH et al. "Influence of cannabis use on severity of hepatitis C disease" Hepatology 2006; 44(4): 268A.
51. Sylvestre DL et al. "Cannabis use improves retention and virological outcomes in patients treated for hepatitis C" Eur J Gastroenterol Hepatol 2006; 18: 1057-1063.